Phase 1/2 open-label dose-escalation study of plasmid DNA expressing two isoforms of hepatocyte growth factor in patients with painful diabetic peripheral neuropathy

Senda Ajroud-Driss, Mark Christiansen, Jeffrey A. Allen, John A. Kessler

Research output: Contribution to journal › Article › peer-review

47 Scopus citations

Fingerprint

Dive into the research topics of 'Phase 1/2 open-label dose-escalation study of plasmid DNA expressing two isoforms of hepatocyte growth factor in patients with painful diabetic peripheral neuropathy'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds